SDIX's Q2 Revenues Rise 4 Percent

Jul 28, 2011

NEW YORK (GenomeWeb News) – Biotech firm SDIX posted a 4 percent hike year over year in revenues for the second quarter, with its Life Science business climbing 13 percent, it reported after the close of the market Thursday.

For the three months ended June 30, revenues increased to $7.1 million, compared to $6.8 million during the second quarter of 2010. Life Science sales rose to $4.2 million from $3.7 million in the year-ago period.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Breaking News

The Scan

Skipped Steps

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

Just a Few Bats

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.